ARTICULATE BIOSCIENCES AWARDED $225,000 PHASE I SBIR GRANT FROM NATIONAL SCIENCE FOUNDATION
The grant will be utilized to further develop the ABX Technology in the company's family of injectable gels, ABX Viscoelastics. The project involves gel formulation and sterilization studies, as well as further biocompatibility testing.
ARTICULATE BIOSCIENCES AWARDED $200,000 PHASE I SBIR GRANT FROM NATIONAL INSTITUTES OF HEALTH
The grant will be used to develop Articulate's ABX Technology for treating osteoarthritis. The company will investigate modes of cartilage protection, cell and tissue biocompatibility, and manufacturing scalability of ABX polymers.